B. A. J. Ponder

6.1k total citations
54 papers, 3.7k citations indexed

About

B. A. J. Ponder is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, B. A. J. Ponder has authored 54 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 22 papers in Genetics and 18 papers in Oncology. Recurrent topics in B. A. J. Ponder's work include BRCA gene mutations in cancer (13 papers), Genetic factors in colorectal cancer (9 papers) and Cancer-related Molecular Pathways (8 papers). B. A. J. Ponder is often cited by papers focused on BRCA gene mutations in cancer (13 papers), Genetic factors in colorectal cancer (9 papers) and Cancer-related Molecular Pathways (8 papers). B. A. J. Ponder collaborates with scholars based in United Kingdom, United States and Canada. B. A. J. Ponder's co-authors include Douglas F. Easton, Margaret A. Ponder, D. Gareth Evans, Simon A. Smith, PD Pharoah, SM Huson, M. Dawn Teare, Lois M. Mulligan, L.V. Crawford and Charis Eng and has published in prestigious journals such as Nature, Cell and The Lancet.

In The Last Decade

B. A. J. Ponder

52 papers receiving 3.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. A. J. Ponder United Kingdom 30 1.6k 1.4k 994 775 733 54 3.7k
B A Ponder United Kingdom 25 1.1k 0.7× 1.3k 1.0× 745 0.7× 444 0.6× 483 0.7× 39 2.7k
A.A. Sandberg United States 38 1.6k 1.0× 808 0.6× 857 0.9× 730 0.9× 609 0.8× 134 4.5k
Joanne Ngeow Singapore 34 1.6k 1.0× 994 0.7× 988 1.0× 897 1.2× 719 1.0× 147 4.0k
David E. Goldgar France 37 2.1k 1.3× 3.2k 2.3× 1.1k 1.1× 820 1.1× 1.1k 1.5× 72 4.9k
Shirley V. Hodgson United Kingdom 29 1.7k 1.1× 1.2k 0.9× 1.2k 1.2× 1.6k 2.0× 1.2k 1.6× 59 3.9k
Hilmi Özçelik Canada 34 2.3k 1.4× 1.1k 0.8× 1.2k 1.2× 636 0.8× 758 1.0× 79 3.6k
Norio Wake Japan 40 1.8k 1.1× 841 0.6× 684 0.7× 317 0.4× 688 0.9× 171 4.6k
Hagay Sobol France 33 859 0.5× 1.5k 1.1× 733 0.7× 647 0.8× 713 1.0× 113 2.8k
Rolf H. Sijmons Netherlands 41 1.7k 1.0× 1.6k 1.2× 1.9k 1.9× 2.3k 3.0× 1.4k 2.0× 147 5.1k
Claes Silfverswärd Sweden 32 525 0.3× 848 0.6× 1.0k 1.0× 608 0.8× 878 1.2× 109 3.4k

Countries citing papers authored by B. A. J. Ponder

Since Specialization
Citations

This map shows the geographic impact of B. A. J. Ponder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. A. J. Ponder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. A. J. Ponder more than expected).

Fields of papers citing papers by B. A. J. Ponder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. A. J. Ponder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. A. J. Ponder. The network helps show where B. A. J. Ponder may publish in the future.

Co-authorship network of co-authors of B. A. J. Ponder

This figure shows the co-authorship network connecting the top 25 collaborators of B. A. J. Ponder. A scholar is included among the top collaborators of B. A. J. Ponder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. A. J. Ponder. B. A. J. Ponder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ambrosch, Andreas, et al.. (2008). Multiple endokrine Neoplasie Typ 2A: Genetisches Screening bei familiärem Tumorsyndrom. DMW - Deutsche Medizinische Wochenschrift. 120(17). 615–619.
2.
Gayther, S., Patricia Harrington, Paul D.P. Pharoah, et al.. (2000). The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer. The Cancer Research Campaign/British Prostate Group United Kingdom Familial Prostate Cancer Study Collaborators.. PubMed. 60(16). 4513–8. 90 indexed citations
3.
Brown, Jacqueline, Alan Coulthard, Adrian K. Dixon, et al.. (2000). Rationale for a national multi-centre study of magnetic resonance imaging screening in women at genetic risk of breast cancer. The Breast. 9(2). 72–77. 19 indexed citations
4.
Stratton, J. F., et al.. (1999). Comparison of Prophylactic Oophorectomy Specimens From Carriers and Noncarriers of a BRCA1 or BRCA2 Gene Mutation. JNCI Journal of the National Cancer Institute. 91(7). 626–628. 81 indexed citations
5.
Davies, Barry R., et al.. (1999). Administration of gonadotropins stimulates proliferation of normal mouse ovarian surface epithelium. Gynecological Endocrinology. 13(2). 75–81. 48 indexed citations
6.
Davies, Barry R., Nelly Auersperg, Sally Worsley, & B. A. J. Ponder. (1998). Transfection of rat ovarian surface epithelium with erb-B2/neu induces transformed phenotypes in vitro and the tumorigenic phenotype in vivo.. PubMed. 152(1). 297–306. 17 indexed citations
7.
Friedman, Lori S., Fiona Thistlethwaite, Veronica Yu, et al.. (1998). Thymic lymphomas in mice with a truncating mutation in Brca2.. PubMed. 58(7). 1338–43. 102 indexed citations
8.
Ponder, B. A. J.. (1997). Cancer and genes: how will molecular biology reshape our clinical practice?. The Netherlands Journal of Medicine. 50(5). 211–215. 2 indexed citations
9.
Mulligan, Lois M. & B. A. J. Ponder. (1995). Genetic basis of endocrine disease: multiple endocrine neoplasia type 2.. The Journal of Clinical Endocrinology & Metabolism. 80(7). 1989–1995. 86 indexed citations
10.
Eng, Charis, Dean P. Smith, Lois M. Mulligan, et al.. (1995). A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC.. PubMed. 10(3). 509–13. 209 indexed citations
11.
Evans, D. Gareth, et al.. (1994). Fortnightly Review: Familial breast cancer. BMJ. 308(6922). 183–187. 51 indexed citations
12.
Ponder, B. A. J.. (1994). The Gene Causing Multiple Endocrine Neoplasia Type 2 (MEN 2). Annals of Medicine. 26(3). 199–203. 10 indexed citations
13.
Wooster, Richard, A.M. Cleton-Jansen, Nadine Collins, et al.. (1994). Instability of short tandem repeats (microsatellites) in human cancers. Nature Genetics. 6(2). 152–156. 340 indexed citations
14.
Rousseau-Merck, M.F., Alan Tunnacliffe, Roland Berger, B. A. J. Ponder, & H.-J. Thiesen. (1992). A cluster of expressed zinc finger protein genes in the pericentromeric region of human chromosome 10. Genomics. 13(3). 845–848. 25 indexed citations
15.
Decker, Robert S., Jonathan M. Moore, B. A. J. Ponder, & James L. Weber. (1992). Linkage mapping of human chromosome 10 microsatellite polymorphisms. Genomics. 12(3). 604–606. 24 indexed citations
16.
Smith, Simon A., Douglas F. Easton, D. Gareth Evans, & B. A. J. Ponder. (1992). Allele losses in the region 17q12–21 in familial breast and ovarian cancer involve the wild–type chromosome. Nature Genetics. 2(2). 128–131. 327 indexed citations
17.
Easton, D.F., G. M. Cox, Alison M. Macdonald, & B. A. J. Ponder. (1991). Genetic susceptibility to naevi – a twin study. British Journal of Cancer. 64(6). 1164–1167. 64 indexed citations
18.
Gardner, Emily, et al.. (1991). Localization of the human O6-methylguanine-DNA methyltransferase gene to chromosome 10q24.33-qter. Genomics. 11(2). 475–476. 9 indexed citations
19.
Ponder, B. A. J.. (1990). Prospects for genetic diagnosis of inherited predisposition to cancer. Trends in biotechnology. 8(4). 98–104. 28 indexed citations
20.
Ponder, B. A. J.. (1981). Looking for genomic changes in cancer cells. Nature. 293(5828). 98–99. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026